Aurobindo’s generic Lodosyn gets FDA OK

Aurobindo has received the Food and Drug Administration’s blessing for Carbidopa tablets in a dosage strength of 25 mg.

The product is the generic of Bausch Health’s Lodosyn tablets, 25mg.

Carbidopa tablets are indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic park which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication.

Carbidopa tablets had a market value of roughly $7.7 million for the 12 months ending August 2019, according to IQVIA.